These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 37007029)

  • 1. RAGE signaling regulates the progression of diabetic complications.
    Taguchi K; Fukami K
    Front Pharmacol; 2023; 14():1128872. PubMed ID: 37007029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
    Stern DM; Yan SD; Yan SF; Schmidt AM
    Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for advanced glycation endproducts and progressive kidney disease.
    Fukami K; Taguchi K; Yamagishi S; Okuda S
    Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):54-60. PubMed ID: 25470016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGE/RAGE in diabetic kidney disease and ageing kidney.
    Wu XQ; Zhang DD; Wang YN; Tan YQ; Yu XY; Zhao YY
    Free Radic Biol Med; 2021 Aug; 171():260-271. PubMed ID: 34019934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.
    Stern D; Yan SD; Yan SF; Schmidt AM
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.
    Chhipa AS; Borse SP; Baksi R; Lalotra S; Nivsarkar M
    Pathol Res Pract; 2019 Nov; 215(11):152643. PubMed ID: 31564569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.
    Yan SF; Ramasamy R; Schmidt AM
    Expert Rev Mol Med; 2009 Mar; 11():e9. PubMed ID: 19278572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE and its ligands in retinal disease.
    Barile GR; Schmidt AM
    Curr Mol Med; 2007 Dec; 7(8):758-65. PubMed ID: 18331234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.
    Ramasamy R; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2011 Dec; 1243():88-102. PubMed ID: 22211895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation.
    Schmidt AM; Hofmann M; Taguchi A; Yan SD; Stern DM
    Semin Thromb Hemost; 2000; 26(5):485-93. PubMed ID: 11129404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAGE and the pathogenesis of chronic kidney disease.
    D'Agati V; Schmidt AM
    Nat Rev Nephrol; 2010 Jun; 6(6):352-60. PubMed ID: 20421886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.
    Ramasamy R; Yan SF; Schmidt AM
    Vascul Pharmacol; 2012; 57(5-6):160-7. PubMed ID: 22750165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases.
    Lee EJ; Park JH
    Genomics Inform; 2013 Dec; 11(4):224-9. PubMed ID: 24465234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [AGEs and RAGE - advanced glycation end-products and their receptor in questions and answers].
    Kalousová M; Zima T
    Vnitr Lek; 2014 Sep; 60(9):720-4. PubMed ID: 25294759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.
    Schmidt AM; Stern DM
    Front Biosci; 2001 Oct; 6():D1151-60. PubMed ID: 11578972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.
    Wendt T; Bucciarelli L; Qu W; Lu Y; Yan SF; Stern DM; Schmidt AM
    Curr Atheroscler Rep; 2002 May; 4(3):228-37. PubMed ID: 11931721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.
    Wendt T; Tanji N; Guo J; Hudson BI; Bierhaus A; Ramasamy R; Arnold B; Nawroth PP; Yan SF; D'Agati V; Schmidt AM
    J Am Soc Nephrol; 2003 May; 14(5):1383-95. PubMed ID: 12707408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking the biology of RAGE in diabetic microvascular complications.
    Manigrasso MB; Juranek J; Ramasamy R; Schmidt AM
    Trends Endocrinol Metab; 2014 Jan; 25(1):15-22. PubMed ID: 24011512
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.